Top 5 Most Read RNS's on Vox Markets for Tuesday 6th September 2022
Episode 873, Sep 06, 2022, 06:51 AM
5. Chariot Limited #CHAR Chariot and Total Eren partner on hydrogen project
Chariot Partners With Total Eren On A Green Hydrogen Project In Mauritania.
(Click here to read the RNS)
4. Pantheon Resources #PANR Operational and Corporate Update
Activities at Alkaid #2 are on schedule and we look forward to flow testing operations commencing.
(Click here to read the RNS)
3. Oracle Power #ORCP - Carbon Credit ITMO Alliance Strategy with KOTRA
The Co has been nominated by the Korea Trade-Investment Promotion Agency ("KOTRA") to develop a strategy to register carbon credits within Pakistan. The intention of this process is to eventually trade carbon credits.
(Click here to read the RNS)
2. Contango Holdings #CGO - Positive Results: Lubu Coking Coal & Coke Tests
Processing has confirmed that, after passing through the wash plant, the coking coal product is of excellent quality.
(Click here to read the RNS)
1. Poolbeg Pharma #POLB - Interim Results
Well capitalised with a strong cash balance of £18.9m as at 30 June 2022 & Significant progress made on developing POLB 001, a treatment for severe influenza. LPS human challenge trial commenced in July 2022 with initial results expected by year end 2022
(Click here to read the RNS)
Chariot Partners With Total Eren On A Green Hydrogen Project In Mauritania.
(Click here to read the RNS)
4. Pantheon Resources #PANR Operational and Corporate Update
Activities at Alkaid #2 are on schedule and we look forward to flow testing operations commencing.
(Click here to read the RNS)
3. Oracle Power #ORCP - Carbon Credit ITMO Alliance Strategy with KOTRA
The Co has been nominated by the Korea Trade-Investment Promotion Agency ("KOTRA") to develop a strategy to register carbon credits within Pakistan. The intention of this process is to eventually trade carbon credits.
(Click here to read the RNS)
2. Contango Holdings #CGO - Positive Results: Lubu Coking Coal & Coke Tests
Processing has confirmed that, after passing through the wash plant, the coking coal product is of excellent quality.
(Click here to read the RNS)
1. Poolbeg Pharma #POLB - Interim Results
Well capitalised with a strong cash balance of £18.9m as at 30 June 2022 & Significant progress made on developing POLB 001, a treatment for severe influenza. LPS human challenge trial commenced in July 2022 with initial results expected by year end 2022
(Click here to read the RNS)